1/ Collated thread for new GI fellows ⭐️GI Fellow Resources ⭐️ ▪️Websites ▪️Guidelines ▪️Apps ▪️Podcasts ▪️Textbooks ▪️Board study ▪️Social media 📲 bit.ly/3KwqCVG (hyperlinked 📄) #GITwitter

I have received multiple faxes from @ExpressScripts telling me that carvedilol is “contraindicated” for patients with cirrhosis This is not acceptable and could result is patient harm if someone were to stop this medication. I advise them to stop this practice

🆕 ACG Guideline Highlights: Adenomatous Colorectal Polyposis Syndromes 🧬 ▪️Germline testing triggers + MGPT panel ▪️FAP/AFAP/MAP surveillance intervals ▪️Gastric & duodenal (Spigelman) mgmt Proud to have contributed concept & content 🔗bit.ly/acg-polyposis-syndrom…

Great weekend at @AmCollegeGastro Early Career Leadership Course ‘26! Honored to take part! Highly recommend introspective assessments like: ▪️ Ikigai ▪️Hogan assessment ▪️Goleman leadership styles Thank you @TrieuMD, @DrBloodandGuts, & @NeenaSAbrahamMD for an amazing course!

“MIRacle Sign” ➡️ inducible reversible blanching on EGD with CO2 insufflation. Clue to diagnose borderline or overt gut ischemia

Lately, I keep hearing that IFX is the only drug with clinical trial in perianal Crohn’s...🧐 So, I’ve updated my cheat sheet on medical therapy trials in perianal CD, summarizing 15 RCTs into just one page. Hope it’s useful! Surgical part coming soon (If any is missing please let me know and I will add it) ⏳➡️ibd-eii.com/cheat-sheet/

The 'pits' on the polyp are base or openings of the crypts. This paper (bookmark!) details the 3D dimension of the crypts: link.springer.com/article/10… As the cells proliferate, the gland architecture distorts, so does the pit pattern. Used in Kudo, JNET, NICE classification

AI is not gonna replace physicians. However, physicians who don’t utilize AI will be replaced. When I am sick I want AI going through all my data and then render an opinion and an excellent clinician doing the same. Then the two of them can work together to fix me.

#CGH4ALL @AGA_CGH 📣 Exciting data in #EoE: A potential step toward restoring dietary freedom while maintaining disease control in EoE. 🔹Open-label pilot study, patients (6–25 yrs) w/ milk/egg/soy/wheat-triggered EoE 🔹Dupilumab for 3 months, followed by stepwise food reintroduction up to 12 months 🔹All completers successfully reintroduced ≥1 trigger food, and many expanded diets every 3 months #GITwitter #MedTwitter 🔗cghjournal.org/article/S1542… Reported by @AasthaBharwad @EdoardoSavarino, @NdeBortoli, @SebastianZeki, @stevenbollipo, @DrCJudge, @my_ueg, @virgisolitano, @eathar_s, @DaniyalAbbasMD

✨ Thank you @gastroendonews for having @JosephHabibi_MD and myself 🗣️ about our latest 📝 on building your social media brand as a GI trainee 🎙️ Grateful to all our coauthors! 🙏🏻 @BilalMohammadMD @CarlKayMD The hard copy is out! Read it today 🫵 📜 l1nq.com/yku7lfq

First double-blind, placebo-controlled RCT in @TheLancet showing that SEMAGLUTIDE reduces ALCOHOL intake in people with BMI >25. Potentially practice-changing. shorturl.at/B45aU

AI in GI training key points ▪️Set competencies & policies ▪️Delay use in endoscopy ▪️Taper autonomy & turn AI off at times ▪️Clinic scribes help; verify output ▪️LLMs are not stand alone ▪️Use evidence tools & cross-check ▪️AI is adjunct not decision maker Keep convo going!

ACG Governors and the Early Career Leadership Program are here for #ACGAdvocacyDay in DC, advocating for GI physicians and patients on key issues like preventive service coverage and prior authorization challenges! Follow along as we check in with them throughout the day. 🧵

💬 Viewpoint: Mandatory annual training modules consume millions of physician‑hours each year, yet their largely passive formats may offer limited educational value while contributing to administrative burden and clinician burnout. ja.ma/4vvyvBm

Traded the endoscopy suite for Capitol Hill today. @AmCollegeGastro Advocacy Day is a reminder that the best outcomes start long before the colonoscopy - sometimes in a congressional office. 🏛️ #GITwitter

Great fun writing this article on landmark papers in decomp cirrhosis and CSPH. Thanks @ReibergerThomas and Prof Tsochatzis for being co-authors and @FrontGastro_BMJ for publishing! Check out 👇 doi.org/10.1136/flgastro-202… @EASLedu @BASLedu @BSGTrainees @AASLDtweets #livertwitter

Love this paper 1. Checking ANA in everyone with elevated ALT is unhelpful, sometimes harmful, usually confusing 2. Biopsy when ALT <100 but ANA elevated is not useful 3. Autoimmune hepatitis is a clinical diagnosis and frequently made DESPITE biopsy findings

Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis - Gastro Hep Advances ghadvances.org/article/S2772…

🤔 Should we be doing routine terminal ileal intubation during colorectal cancer screening colonoscopy? 🔦 💡 No, according to the results of a newly published meta-analysis 👇

The Augmented Colonoscopy With Computer-Aided Polyp Characterization Study: Prospective Study Comparing the Diagnostic Reliability of Optical Diagnosis of Trainees With Experts Without Artificial Intelligence Bernhofer & Prosenz, et al. 📕 doi.org/10.14309/ajg.0000000…

“You may choose not to use OpenEvidence or GPT… You may choose not to play around with Claude… but to not be intrigued by it, by the possibilities, to even explore whether it might help you or your patients, to me, at some point begins to border on malpractice.” @Bob_Wachter